The Patent Cliff and Growing Generic Competition: How Pharmaceutical Market Research Can Support Portfolio Decisions
Patent expirations can transform a pharmaceutical product's commercial outlook. As established medicines approach the end of their market protection, manufacturers may face generic or biosimilar competition, changing prices, and pressure on revenue. Yet the impact is rarely uniform across products or markets. Some medicines attract multiple competitors, while others face delayed or limited entry. For pharmaceutical companies, the challenge is deciding where to defend existing business, where to invest, and which opportunities deserve closer attention. Healthcare market research , specifically pharmaceutical market research, can help address these challenges by providing insights into competitive developments, market demand, and emerging growth opportunities. This article examines the patent cliff, its implications for portfolio planning, and how pharmaceutical market research can support evidence-based decisions in an increasingly competitive environment. Understanding the Pharma...